Valeant's debt-fueled castoffs continue with half-priced Obagi sale
admin 17th July 2017 Uncategorised 0It’s been more than a year since analysts first said Valeant could sell off its Obagi Medical Products business in a cash-raising effort, but the Canadian drugmaker has finally found a taker.
More: Valeant's debt-fueled castoffs continue with half-priced Obagi sale
Source: fierce